Postoperative Problems 2011: Fundoplication and Obesity Surgery

Gastroenterology Clinics of North America

Volumn 40, Issue 4, 2011, Pages 809-821

  Rohof, W O ^a   Bisschops, R ^b   Tack, J ^b   Boeckxstaens, G E ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Bariatric surgery; Dumping syndrome; Dysphagia; Fundoplication; GERD

Indexed keywords

ACARBOSE; ANGIOPEPTIN; ANTACID AGENT; ANTIDEPRESSANT AGENT; BACLOFEN; LONG ACTING DRUG; OCTREOTIDE; PLACEBO; PROTON PUMP INHIBITOR; SHORT ACTING DRUG; SOMATOSTATIN DERIVATIVE;

ANTIREFLUX OPERATION; BARIATRIC SURGERY; BLOATING; DIARRHEA; DIET THERAPY; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFECT; DYSPEPSIA; DYSPHAGIA; ESOPHAGEAL DYSMOTILITY DISORDER; ESOPHAGUS DILATATION; ESOPHAGUS FUNCTION DISORDER; FLATULENCE; GALLSTONE FORMATION; GASTRIC BANDING; GASTROESOPHAGEAL REFLUX; HEARTBURN; HUMAN; LOW DRUG DOSE; NON EROSIVE REFLUX DISEASE; OBESITY; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POSTGASTRECTOMY SYNDROME; POSTOPERATIVE COMPLICATION; RECURRENT DISEASE; REFLUX ESOPHAGITIS; REVIEW; SATIETY; STEATORRHEA; STOMACH FUNDOPLICATION; TREATMENT DURATION;

EID: 81455143642     PISSN: 08898553     EISSN: 15581942     Source Type: Journal    
DOI: 10.1016/j.gtc.2011.09.002     Document Type: Review

References (73)

1. Ogden C.L., Carroll M.D., Curtin L.R., et al. Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006, 295:1549-1555.
2. Nguyen D.M., El-Serag H.B. The epidemiology of obesity. Gastroenterol Clin North Am 2010, 39:1-7.
3. Dent J., El-Serag H.B., Wallander M.A., et al. Epidemiology of gastro-oesophageal reflux disease: a systematic review. Gut 2005, 54:710-717.
4. Sjostrom L., Lindroos A.K., Peltonen M., et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med 2004, 351:2683-2693.
5. Sjostrom L., Gummesson A., Sjostrom C.D., et al. Effects of bariatric surgery on cancer incidence in obese patients in Sweden (Swedish Obese Subjects Study): a prospective, controlled intervention trial. Lancet Oncol 2009, 10:653-662.
6. Sjostrom L., Narbro K., Sjostrom C.D., et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med 2007, 357:741-752.
7. Catona A., Gossenberg M., La M.A., et al. Laparoscopic gastric banding: preliminary series. Obes Surg 1993, 3:207-209.
8. Wright T.A., Kow L., Wilson T., et al. Early results of laparoscopic Swedish adjustable gastric banding for morbid obesity. Br J Surg 2000, 87:362-373.
9. Naef M., Naef U., Mouton W.G., et al. Outcome and complications after laparoscopic Swedish adjustable gastric banding: 5-year results of a prospective clinical trial. Obes Surg 2007, 17:195-201.
10. Naef M., Mouton W.G., Naef U., et al. Esophageal dysmotility disorders after laparoscopic gastric banding: an underestimated complication. Ann Surg 2011, 253:285-290.
11. Huang C.S., Forse R.A., Jacobson B.C., et al. Endoscopic findings and their clinical correlations in patients with symptoms after gastric bypass surgery. Gastrointest Endosc 2003, 58:859-866.
12. Tack J., Arts J., Caenepeel P., et al. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol 2009, 6:583-590.
13. Tack J. Gastric motor and sensory function. Curr Opin Gastroenterol 2009, 25:557-565.
14. Tack J., Piessevaux H., Coulie B., et al. Role of impaired gastric accommodation to a meal in functional dyspepsia. Gastroenterology 1998, 115:1346-1352.
15. Abell T.L., Minocha A. Gastrointestinal complications of bariatric surgery: diagnosis and therapy. Am J Med Sci 2006, 331:214-218.
16. Zaloga G.P., Chernow B. Postprandial hypoglycemia after Nissen fundoplication for reflux esophagitis. Gastroenterology 1983, 84:840-842.
17. Mayer E.A., Thompson J.B., Jehn D., et al. Gastric emptying and sieving of solid food and pancreatic and biliary secretion after solid meals in patients with truncal vagotomy and antrectomy. Gastroenterology 1982, 83(1 Pt 2):184-192.
18. Vecht J., Masclee A.A., Lamers C.B. The dumping syndrome. Current insights into pathophysiology, diagnosis and treatment. Scand J Gastroenterol Suppl 1997, 223:21-27.
19. Bloom S.R., Royston C.M., Thomson J.P. Enteroglucagon release in the dumping syndrome. Lancet 1972, 2(7781):789-791.
20. Lawaetz O., Blackburn A.M., Bloom S.R., et al. Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis. Scand J Gastroenterol 1983, 18:73-80.
21. Toft-Nielsen M., Madsbad S., Holst J.J. Exaggerated secretion of glucagon-like peptide-1 (GLP-1) could cause reactive hypoglycaemia. Diabetologia 1998, 41:1180-1186.
22. van der Kleij F.G., Vecht J., Lamers C.B., et al. Diagnostic value of dumping provocation in patients after gastric surgery. Scand J Gastroenterol 1996, 31:1162-1166.
23. Arts J., Caenepeel P., Bisschops R., et al. Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping. Clin Gastroenterol Hepatol 2009, 7:432-437.
24. McLoughlin J.C., Buchanan K.D., Alam M.J. A glycoside-hydrolase inhibitor in treatment of dumping syndrome. Lancet 1979, 2(8143):603-605.
25. Gerard J., Luyckx A.S., Lefebvre P.J. Acarbose in reactive hypoglycemia: a double-blind study. Int J Clin Pharmacol Ther Toxicol 1984, 22:25-31.
26. Lyons T.J., McLoughlin J.C., Shaw C., et al. Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome. Digestion 1985, 31(2-3):89-96.
27. Hasegawa T., Yoneda M., Nakamura K., et al. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome. J Gastroenterol Hepatol 1998, 13:1201-1206.
28. Hopman W.P., Wolberink R.G., Lamers C.B., et al. Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995. Ann Surg 1988, 207:155-159.
29. Primrose J.N., Johnston D. Somatostatin analogue SMS 201-995 (octreotide) as a possible solution to the dumping syndrome after gastrectomy or vagotomy. Br J Surg 1989, 76:140-144.
30. Tulassay Z., Tulassay T., Gupta R., et al. Long acting somatostatin analogue in dumping syndrome. Br J Surg 1989, 76:1294-1295.
31. Geer R.J., Richards W.O., O'Dorisio T.M., et al. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome. Ann Surg 1990, 212:678-687.
32. Richards W.O., Geer R., O'Dorisio T.M., et al. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome. J Surg Res 1990, 49:483-487.
33. Gray J.L., Debas H.T., Mulvihill S.J. Control of dumping symptoms by somatostatin analogue in patients after gastric surgery. Arch Surg 1991, 126:1231-1235.
34. Hasler W.L., Soudah H.C., Owyang C. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome. J Pharmacol Exp Ther 1996, 277:1359-1365.
35. Didden P., Penning C., Masclee A.A. Octreotide therapy in dumping syndrome: analysis of long-term results. Aliment Pharmacol Ther 2006, 24:1367-1375.
36. Nissen R. A simple operation for control of reflux esophagitis. Schweiz Med Wochenschr 1956, 86(Suppl 20):590-592.
37. Toupet A. Technic of esophago-gastroplasty with phrenogastropexy used in radical treatment of hiatal hernias as a supplement to Heller's operation in cardiospasms. Mem Acad Chir (Paris) 1963, 89:384-389.
38. Broeders J.A., Mauritz F.A., Ahmed A.U., et al. Systematic review and meta-analysis of laparoscopic Nissen (posterior total) versus Toupet (posterior partial) fundoplication for gastro-oesophageal reflux disease. Br J Surg 2010, 97:1318-1330.
39. Mardani J., Lundell L., Engstrom C. Total or posterior partial fundoplication in the treatment of GERD: results of a randomized trial after 2 decades of follow-up. Ann Surg 2011, 253:875-878.
40. Bredenoord A.J., Draaisma W.A., Weusten B.L., et al. Mechanisms of acid, weakly acidic and gas reflux after anti-reflux surgery. Gut 2008, 57:161-166.
41. Broeders J.A., Bredenoord A.J., Hazebroek E.J., et al. Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut 2011, 60:435-441.
42. Bais J.E., Bartelsman J.F., Bonjer H.J., et al. Laparoscopic or conventional Nissen fundoplication for gastro-oesophageal reflux disease: randomised clinical trial. The Netherlands Antireflux Surgery Study Group. Lancet 2000, 355(9199):170-174.
43. Strate U., Emmermann A., Fibbe C., et al. Laparoscopic fundoplication: Nissen versus Toupet two-year outcome of a prospective randomized study of 200 patients regarding preoperative esophageal motility. Surg Endosc 2008, 22:21-30.
44. Mickevicius A., Endzinas Z., Kiudelis M., et al. Influence of wrap length on the effectiveness of Nissen and Toupet fundoplication: a prospective randomized study. Surg Endosc 2008, 22:2269-2276.
45. Lundell L. Complications after anti-reflux surgery. Best Pract Res Clin Gastroenterol 2004, 18:935-945.
46. Hunter J.G., Swanstrom L., Waring J.P. Dysphagia after laparoscopic antireflux surgery. The impact of operative technique. Ann Surg 1996, 224:51-57.
47. Gill R.C., Bowes K.L., Murphy P.D., et al. Esophageal motor abnormalities in gastroesophageal reflux and the effects of fundoplication. Gastroenterology 1986, 91:364-369.
48. Tsuboi K., Lee T.H., Legner A., et al. Identification of risk factors for postoperative dysphagia after primary anti-reflux surgery. Surg Endosc 2011, 25:923-929.
49. Broeders J.A., Sportel I.G., Jamieson G.G., et al. Impact of ineffective oesophageal motility and wrap type on dysphagia after laparoscopic fundoplication. Br J Surg 2011.
50. Sayuk G.S., Clouse R.E. Management of esophageal symptoms following fundoplication. Curr Treat Options Gastroenterol 2005, 8:293-303.
51. Furnee E.J., Draaisma W.A., Broeders I.A., et al. Surgical reintervention after antireflux surgery for gastroesophageal reflux disease: a prospective cohort study in 130 patients. Arch Surg 2008, 143:267-274.
52. Kessing B., Bredenoord A.J., Smout A.J. Erroneous Diagnosis of Gastroesophageal Reflux Disease in Achalasia. Clin Gastroenterol Hepatol 2011.
53. Scheffer R.C., Samsom M., Haverkamp A., et al. Impaired bolus transit across the esophagogastric junction in postfundoplication dysphagia. Am J Gastroenterol 2005, 100:1677-1684.
54. Pandolfino J.E., Ghosh S.K., Lodhia N., et al. Utilizing intraluminal pressure gradients to predict esophageal clearance: a validation study. Am J Gastroenterol 2008, 103:1898-1905.
55. Lamb P.J., Myers J.C., Jamieson G.G., et al. Long-term outcomes of revisional surgery following laparoscopic fundoplication. Br J Surg 2009, 96:391-397.
56. Hui J.M., Hunt D.R., de Carle D.J., et al. Esophageal pneumatic dilation for postfundoplication dysphagia: safety, efficacy, and predictors of outcome. Am J Gastroenterol 2002, 97:2986-2991.
57. Wo J.M., Trus T.L., Richardson W.S., et al. Evaluation and management of postfundoplication dysphagia. Am J Gastroenterol 1996, 91:2318-2322.
58. Malhi-Chowla N., Gorecki P., Bammer T., et al. Dilation after fundoplication: timing, frequency, indications, and outcome. Gastrointest Endosc 2002, 55:219-223.
59. Gaudric M., Sabate J.M., Artru P., et al. Results of pneumatic dilatation in patients with dysphagia after antireflux surgery. Br J Surg 1999, 86:1088-1091.
60. Ellingson T.L., Kozarek R.A., Gelfand M.D., et al. Iatrogenic achalasia. A case series. J Clin Gastroenterol 1995, 20:96-99.
61. Fumagalli U., Bona S., Battafarano F., et al. Persistent dysphagia after laparoscopic fundoplication for gastro-esophageal reflux disease. Dis Esophagus 2008, 21:257-261.
62. Broeders J.A., Rijnhart-de Jong H.G., Draaisma W.A., et al. Ten-year outcome of laparoscopic and conventional nissen fundoplication: randomized clinical trial. Ann Surg 2009, 250:698-706.
63. Pessaux P., Arnaud J.P., Delattre J.F., et al. Laparoscopic antireflux surgery: five-year results and beyond in 1340 patients. Arch Surg 2005, 140:946-951.
64. Lindeboom M.A., Ringers J., Straathof J.W., et al. Effect of laparoscopic partial fundoplication on reflux mechanisms. Am J Gastroenterol 2003, 98:29-34.
65. Broeders J.A., Bredenoord A.J., Hazebroek E.J., et al. Effects of anti-reflux surgery on weakly acidic reflux and belching. Gut 2011, 60:435-441.
66. Galmiche J.P., Hatlebakk J., Attwood S., et al. Laparoscopic antireflux surgery vs esomeprazole treatment for chronic GERD: the LOTUS randomized clinical trial. JAMA 2011, 305:1969-1977.
67. Spechler S.J. Comparison of medical and surgical therapy for complicated gastroesophageal reflux disease in veterans. The Department of Veterans Affairs Gastroesophageal Reflux Disease Study Group. N Engl J Med 1992, 326:786-792.
68. Broeders J.A., Roks D.J., Draaisma W.A., et al. Predictors of objectively identified recurrent reflux after primary Nissen fundoplication. Br J Surg 2011, 98:673-679.
69. Fass R., Sifrim D. Management of heartburn not responding to proton pump inhibitors. Gut 2009, 58:295-309.
70. Vela M.F., Tutuian R., Katz P.O., et al. Baclofen decreases acid and non-acid post-prandial gastro-oesophageal reflux measured by combined multichannel intraluminal impedance and pH. Aliment Pharmacol Ther 2003, 17:243-251.
71. Koek G.H., Sifrim D., Lerut T., et al. Effect of the GABA(B) agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors. Gut 2003, 52:1397-1402.
72. Lindeboom M.Y., Ringers J., van Rijn P.J., et al. Gastric emptying and vagus nerve function after laparoscopic partial fundoplication. Ann Surg 2004, 240:785-790.
73. Bredenoord A.J., Chial H.J., Camilleri M., et al. Gastric accommodation and emptying in evaluation of patients with upper gastrointestinal symptoms. Clin Gastroenterol Hepatol 2003, 1:264-272.